1. Field of the Invention
A device, such as a flexible spinal fusion cage, which can articulate or bend in such a way that it will be able to be implanted through bone (i.e., in a trans-osseous path, through bone, such as the Ilium and/or sacrum joint approach into L5-S1 is disclosed.
2. Description of the Related Art
Typical lateral approach fusion implants (e.g., Nuvasive XLIF, Medtronic DLIF) are not able to implant into some orthopedic target sites for a variety of reasons.
Boney obstacles can impair access.
Some doctors create large windows through the Ilium 14 to gain direct line of site access. This is a highly invasive approach removing a significant portion of bone, and requires significant surgical skill. Because of the inflexibility of the typical implants, the windows must be large enough to fit the entire implant cross section.
Furthermore, with the retractor positioned in the plane/direction as shown by the purple arrows above, the angle formed between the arrow tip and the VB's end plates would make inserting a monolithic fusion cage virtually impossible. A close up of this is shown below. A typical lateral fusion cage (gold) is the width of the end plate (a shown by the dotted lines) by the height if the disk (as shown by the parallel horizontal lines). The stiff, monolithic implant can be difficult if not impossible to turn around the corner at the lateral and/or anterior edge of the L5-S1 intervertebral space, as shown (as the bold circular dot) in
Typical treatments for L5-S1 include anterior approaches, through the belly, TLIF (transforaminal lumbar interbody fusion), and PLIF (Posterior lumbar interbody fusion). Anterior and TLIF approaches are the most used. Both approaches are typically invasive.
Support or fixation devices and methods for access, controlling (steering) implants, and modifying implants are disclosed.
The device can be an implantable fixation device, such as a flexible fusion cage. The device can articulate and/or bend so the device can be delivered through a channel in one or more bones and into the L5-S1 intervertebral space, as shown in
A stand-alone fusion system and method is disclosed that can include deploying the support device with the transosseous delivery approach and optionally deploying screws and using targeting fixtures.
a and 1b are direct anterior and anterior perspective views, respectively, of a variation of the lower lumbar spine.
a and 8b illustrate variations of and a delivery method for the implant support device.
a through 9c illustrate a variation of the implant support device and variations of delivery methods.
a and 11b are superior views of the sacrum and variations Of methods for deploying multiple implant devices.
a and 12b are side and side perspective views of a variation of a deployment tool for deploying support devices in the spine with a reamer wire and an anchor wire.
a through 13c are side, side perspective, and rear perspective views of the tool in
a and 15b are side perspective and top perspective views, respectively, of the tool of
c is a close up view, of the tool of
a and 16b are a side view and a close-up side view, respectively, of a skeleton showing various visualization perspectives of a target site.
a through 17g are an anterior-posterior view from the posterior, a lateral view, an isometric view, an anterior-posterior view from the anterior, an inlet view, a close-up inlet view, and an outlet view, respectively, of a variation of a method for placing an anchor wire at a target site.
a is a lateral view of a variation of a method of placement of the wire guide, the anchor wire and the reamer wire, and an additional side perspective view of the guide tool for illustrative purposes.
b and 18c are outlet and inlet views, respectively, of a variation of the placement of the reamer wire.
a and 21b are perspective and sectional views of the target site during a variation of a method of placing the anchor wire and reamer wire in the spine.
a illustrates a method for inserting the reamer wire into the intervertebral space.
b illustrates a method for creating a bone channel and inserting a reamer into the intervertebral space.
a through 25d illustrate variations of the support device.
a through 26d illustrate a variation of a method for delivering a variation of the support device through the bone channel, into the intervertebral space, and filling the bone channel.
a through 27c illustrate variations of the support device.
a through 28d illustrate a variation of a method for delivering a variation of the support device through the bone channel, into the intervertebral space, and filling the bone channel.
a through 29d illustrate a variation of a method for delivering a variation of the support device through the bone channel, into the intervertebral space, and filling the bone channel.
Implantable orthopedic support devices and methods for implanting the same that can provide surgeons access, control (i.e., steering, translation) and implant into the L5-S1 disc space are disclosed. The method can deliver the device traveling through a tunnel drilled through the Sacroiliac joint into the L5-S1 joint space. The delivery method can be performed without disrupting nerves and major blood vessels. The implant has additional hardware to “lock” or stabilize the implant and the connect L5 to S1.
The support device can be one or more flexible fusion devices, such as unibody or multi-part cages or stents. The support devices can articulate and/or bend, for example to be able to make a sharp turn from exiting a transosseous bone channel and entering into the L5-S1 disc space. The support devices can have rigid sections connected by articulatable axes (e.g., hinges), or rigid sections and flexible lengths, or be flexible along the entire length of the device, or combinations thereof.
The bone channel 30 can be fitted with a collar or tube in contact with the perimeter of the channel. The collar or tube can be attached to a trocar. The tube can be delivered into the channel separate from a trocar. The tube can be hollow. The tube can have one, two, three or more lumens. The implant device can be inserted through the tube. The tube lumen(s) can have a low friction internal surface. For example, the internal surface can be coated with PTFE (e.g., Teflon).
Access tools, such as elongated retractors that can be fit through the move soft tissue out of the way to create the channel 30. The distal end of the implanted support device 32 can be atraumatic, but come to a rounded tip to spread or dissect tissue away from the delivery path 22 during translation of the device 32 during delivery.
One or more deployment tools can delivery and deploy the support device 32. The deployment tools can allow the support device 32 to passively articulate or flex in response to resistive forces from surrounding tissue and/or actively articulate or flex the support device upon control inputs (e.g., pushing, twisting, button pressing, level manipulation, etc.) from the user. The interface or connection between the deployment tool and the support device 32 can bend, flex, steer, or a combination thereof. The deployment tool or tools can clear out the disk space 12 (i.e., performing a partial or complete discectomy). The deployment tools can articulate and/or flex and follow the delivery paths shown for the support device herein, for example to reach the L4-L5 and/or L5-S1 disc space 12a and/or 12b. The deployment tools can be pre-angled to reach and remove disk material, for example the deployment tool can be rigid and bent or flex.
A stand alone fusion system and method can include utilizing the support device in a transosseous approach optionally with additional securing and/or targeting devices.
a through 9 illustrate that additional securing devices 34 and methods can be used to fix, stabilize, help heal, minimize or prevent migration of the support device 32, reduce bone (e.g., L4, L5, S1, and combinations thereof) movement relative to the support device 32 and relative to the other bones, and combinations thereof. The supplement stabilization elements or securing devices 34 can secure the position of the flexible implant to the surrounding bone. The support device 32 can completely fuse to the ends plates of the surrounding bone (e.g., L4, L5, S1, and combinations thereof). Other securing devices 34 can be used in combination with the support device 32 such as facet fusion elements, pedicle-based screws and rods, anterior plates, and combinations thereof.
a illustrates that the support device 32 can be long enough and/or inserted at a length into the disc space 12 so that a portion of the support device 32 extends into the bone channel 30 after the insertion is complete. The portion of the support device 32 inside of the bone channel 30 can be straight or at an angle to the portion of the support device 32 directly adjacent and on the outside of the bone channel 30. For example, the support device 32 can be flexible through the distal ⅔ of the length of the support device 32 and the proximal ⅓ of the length of the support device 32 can be rigid or not flexible, but articulatable with the distal ⅔ of the length of the support device 32. The proximal ⅓ of the length of the support device 32 can remain within the sacrum access tunnel or bone channel 30 after the support device 32 is positioned at the target site in the disc space 12. The stiff proximal section 36 of the support device 32 can be hingedly and/or flexibly connected to the distal length of the support device 32. The support device 32 can be fixed to the bone channel 30, for example at the proximal length 36 of the support device 32. The proximal end 36 of the support device 32 can be glued, impacted, screwed, or a combination thereof, to the bone channel 30 and/or to a collar in the bone channel 30. The support device proximal rigid end 36 can be made from any material listed herein including PEEK, allograft, Ti, PE, PMMA, milled bone, steel, or combinations thereof.
The proximal and/or distal ends of the support device 32 can have a porous bone ingrowth matrix on the outer surfaces of the support device 32, for example promoting bone growth into the support device fixing the support device to surrounding bone (e.g., in the bone channel and/or L4, L5, and/or S1). The proximal, distal or entire length of the support device can be hollow, cannulated, threaded, have teeth, be expandable, barbed, be multiple pieces, or combinations thereof (e.g., to promote bone growth into the support device).
b illustrates that an interference screw 34 can anchor the stiff or flexible proximal section 36 of the support device 32. The interference screw 34 can be inserted between the proximal length 36 of the support device 32 and the bone channel 30 and/or between the distal length of the support device 32 and the adjacent bone 10. The interference screw 34 can pressure-fit the support device 32 against the bone channel 30 and/or adjacent bone 10. The interference screw 34 can be inserted parallel with the longitudinal axis of the length of the support device 32 adjacent to the interference screw 34. The interference screw 34 can be made from any material listed herein including PEEK, allograft, Ti, PE, PMMA, milled bone, steel, or combinations thereof.
a through 9c illustrate that the support device can have additional transosseous single, double, or crossing lag screws, bolts, spears, tacks, or other anchors or securing devices (referred to as “screws”) 34 inserted through or around the support device 32 and into surrounding bone 10 and/or soft tissue. The screws 34 can pass through the support device 32 or outside the support device 32 in front, back and/or to the side of the support device 32 (i.e., anteriorly, posteriorly and/or laterally).
The outer diameter of the screws 34 can be larger, smaller or the same as the inner diameter of the bone channel (or tube lumen) through which the respective screw 34 is to be delivered. The proximal ends of the screws 34 can be threaded or smooth. The proximal end of the screws 34 can be can be inside a larger diameter plug smaller than, equal to or larger than the bone channel or tube lumen inner diameter. The screws 34 can be rigid.
a illustrates that a single screw 34 can be inserted through a bone channel 30.
a and 11b illustrate that first and second support devices 32a and 32b can be inserted into the target site. The first support device 32a can be anterior or posterior, lateral or medial, superior or inferior (e.g., in contact or in different disc spaces such as a first support device 32a in the L4-L5 space 12a and the second support device 32b in the L5-S1 space 12b), or a combination thereof of the second support device 32b. For example, different diameter support devices 32 can be inserted through different diameter bone channels 30 and/or tube lumens (e.g., larger diameter support devices 32 can be inserted through larger diameter bone channels 30 and smaller diameter support devices 32 can be inserted through smaller bone channels 30).
Each bone channel 30 can have a medial bone channel port 40a and a lateral bone channel port 40b. The lateral bone channel port 40b can be on the lateral side of the Ilium. The medial bone channel port 40a can be at the bone face exposed to the target site, such as adjacent to and in fluid communication with the respective intervertebral disc space.
a and 12b illustrate a guidance tool (i.e., guide tool) 42 that can be used to guide wires used to access the target site, such as the L5-S1 vertebral joint space 12b. The guide tool 42 can have a handle 44, a guide base 46, a wire holding fixture 48 or combinations thereof. The handle 44 can be releasably or fixedly attached to the guide base 46. The guide base 46 can be fixedly or releasably attached to the wire holding fixture 48. The guide base 46 can have a fixture lock 50 that can attach and release the wire holding fixture 48 to the guide base 46.
The wire holding fixture 48 can have an outer fixture 52a and an inner fixture 52b. The outer fixture 52a and the inner fixture 52b can have radii of curvature 54a and 54b, respectively, with respect to a target lateral axis 56a from about 4 in. to about 10 in., more narrowly from about 5.5 in. to about 7 in., for example about 5.5 in. or about 6 in., and radii of curvature with respect to a target vertical axis 56b from about 4 in. to having no curvature with respect to the target vertical axis 56b, more narrowly from about 4 in. to about 10 in., more narrowly from about 5.5 in. to about 7 in., for example about 5.5 in. or about 6 in. The outer and inner fixture radii of curvature about the target lateral axis can be the same or different as the radii of curvature about the target vertical axis.
The outer fixture 52a can be radially separated by a gap from the inner fixture 52b.
The outer fixture 52a and inner fixture 52b can have one or more reamer wire holes. The outer fixture 52a can have outer lateral reamer wire holes 58a and outer central reamer wire holes 58b. The inner fixture 52b can have inner lateral reamer wire holes 60a and inner central reamer wire holes 60b. Each central reamer wire hole can have a lateral reamer wire hole on one or both lateral sides of the central reamer wire hole, forming reamer wire hole rows. The outer reamer wire holes can align radially with the inner reamer wire holes.
The reamer wire hole rows can be spread apart by about 5° increments. The reamer wire holes can be replaced or used in addition to a reamer wire holder on a track that can be slid up and down the wire holding fixture (e.g., like a protractor), being adjustable, for example, in infinitely small increments within the range allowed by the fixture.
The wire holding fixture 48 can have a visualization pin hole 62, for example, at the terminal end of the wire holding fixture 48 away from the guide base 46. The visualization pin hole 62 can be configured to hold a pin substantially parallel to the anchor wire 64.
The anchor wire 64 can extend from the guide base 46 colinear or parallel to the handle 44. The anchor wire 64 can be releasably attached to the guide base 46. The guide base 46 can have an anchor lock 66 to releasably fix the anchor wire 64 to the guide base 46. A length of the anchor wire 64 can be slid into the guide base 46 before securing, locking or otherwise fixing the anchor wire 64 to the guide base 46.
The reamer wire 68 can slide through the desired reamer wire holes 58 and/or 60. The reamer wire 68 can be slidably received by the reamer wire holes 58 and/or 60. The reamer wire 68 can be cannulated.
The use of the word “wire” to describe the anchor wire 64, reamer wire 68 or other wires is exemplary only. The wires can be hollow or solid and can be rods, leaders, staffs, shafts, needles, trocars, pins, bars, cylinders, poles, bars, or combinations thereof. The wires can have cross-sections of circular, oval, square, triangular, rectangular shape, or combinations thereof. The anchor wire can have a diameter from about 1 mm to about 10 mm, more narrowly from about 3 mm to about 5 mm, for example about 3 mm or about 4 mm. The reamer wire can have a diameter from about 1 mm to about 10 mm, more narrowly from about 2 mm to about 4 mm, for example about 3 mm or about 4 mm.
The reamer wire 68 can extend to intersect and contact the anchor wire 64 at a guide target location 70. The reamer wire distal terminal tip 72 and the anchor wire distal terminal tip 74 can meet or touch or almost meet or touch at the guide target location 70. The guide target location 70 can be the origin location for the target lateral axis 56a and the target vertical axis 56b. The guide target location 70 can be placed in or adjacent to the desired target vertebral disc space 12 and/or the medial bone channel port 40a.
a and 13b illustrate that a visualization guidance pin 76 can extend through the visualization pin hole. The visualization guidance pin can be parallel with the anchor wire. The visualization guidance pin 76, anchor wire 64 and reamer wire 66 can be co-planar with any combination or all of each other.
The visualization guidance pin 76 can be highly visible for a chosen visualization technique. For example, all or part of the visualization guidance pin 76 can be radiopaque, echogenic, radioactive, magnetic, fluorescing, electrically conductive or resistant, or combinations thereof. The visualization guidance pin can be configured to be observed with the naked eye, MRI, x-ray, CAT scanning, sonograms, fluoroscopy, or combinations thereof.
The guidance tool 42 can hold the guidance pin 76 at an orientation and position so the guidance pin 76 does or does not contact or pierce the patient.
The distal terminal end of the reamer wire can have a reamer wire tip 72. The distal terminal end of the anchor wire can have an anchor wire tip 74. The wire tips 72 and 74 can have chisel tip, bullet tip, needle tip and/or hollow tip configurations.
One or both of the wire tips 72 and/or 74 can have a visualization marking the same or different from the remainder of the respective wire. For example, the wire tips can be radiopaque whether or not the remainder of the wire is radiopaque. Similarly, the wire tips can be echogenic, magnetic, radioactive, fluorescing, electrically conductive or resistant, or combinations thereof.
a through 15c illustrate that the guide tool 42 can be disassembled. For example, the wire holding fixture can be separated from and re-attached to the guide base. During use, after the reamer wire is in position with the reamer wire tip at the target site, the wire holding fixture can be separated from the guide base. The fixture lock can be turned to release the wire holding fixture from the guide base. The anchor wire can then be removed from the target site by pulling the handle and the wire holding fixture can be slid off the reamer wire, leaving only the reamer wire at the target site.
c illustrates that the wire holding fixture 48 can have a fixture interface 80, such as a tongue, and the guide base 46 can have a base interface 82 such as a groove. The fixture interface can releasably and slidably attach to the base interface. The fixture interface and the base interface can be configured to prevent or minimize separation of the wire holding fixture from the guide base in any direction other than parallel with the anchor wire.
a and 16b illustrate inlet views, perpendicular to the S1 end plate, shown by arrow 84a, and outlet view parallel to the S1 end plate, shown by arrow 84b, used for visualizing a target site of the L5-S1 vertebral joint.
a through 17g illustrate the initial anchor wire placement parallel to the S1 end plate, through the Ilium and sacroiliac joint, for example, performed with lateral view visualization (e.g., X-ray). The anchor wire 64 can be inserted along an anchor wire delivery path 86 through the Ilium. The anchor wire tip 74 can be inserted through the bone. The anchor wire tip 74 can be positioned in the S1 vertebra 10d inferior and adjacent to the S1 vertebral body endplate, as indicated by anchor wire target site position “x” 88 in
f illustrates an exemplary anterior to posterior target range, as shown by arrows 90, of a targeted placement of the anchor wire tip 74 in the S1 vertebra. For example, the resulting exit point of the access hole into the S1 endplate 92b can correlate to the desired position of the medial bone channel port.
The anchor wire can be delivered through the Ilium and/or ala.
a illustrates that after the anchor wire 64 is inserted into the target site, for example with the anchor wire tip 74 adjacent to the S1 vertebral body end plate 92b, the guide base 46 and the remainder of the guide tool 42 can be attached to the proximal end of the anchor wire 64 extending from the body. The anchor wire 64 can be fixed to the guide base 46 with the anchor lock 66. The guide tool is shown in partial see-through for illustrative purposes.
The reamer wire can then be inserted through a desired set of reamer wire holes. The approach angle of the reamer wire can be controlled by the selected reamer wire hole position. A position closer to the terminal end of the wire holder fixture can deliver the reamer wire at a higher angle relative to the anchor wire. The reamer wire can be inserted through the Ilium and ala, for example by pushing, turning or hammering, to position the reamer wire tip adjacent to or in contact with the anchor wire tip.
The reamer wire and/or the anchor wire can be delivered to the target site substantially entirely through bone after insertion into the Ilium (e.g., through superficial tissue and then into the Ilium and then through bone the entire length until the wire reaches the inside of the S1 vertebral body endplate).
The visualization guidance pin can be inserted into the visualization pin hole. The visualization guidance pin can extend parallel to the anchor wire on the outside of the patient. The visualization guidance pin can make no puncture or other wound in the patient during use.
b and 18c illustrate that the visualization guidance pin can form a plane with the reamer wire and the anchor wire in the inlet view to insure that the delivery of the reamer wire is in the desired orientation. The plane over the sacrum ala can be indicated, as shown in
a and 21b illustrate the reamer wire tip and anchor wire tip positioned at the guide target location. The guide target location, anchor wire tip, and reamer wire tip can be inside the sacrum bone adjacent to the endplate. The guide target location, anchor wire tip, and reamer wire tip can be (an exemplary distance) of about 5-10 mm under the endplate in the sacrum, for example in the cancellous bone of the sacrum.
a illustrates that the reamer wire can be forced, as shown by arrow, through the S1 vertebral end plate and into the intervertebral disc.
b illustrates that a cannulated reamer can be translated, as shown by arrow, over the reamer wire. The reamer can enter the intervertebral space. The reamer can open a hole in the S1 vertebral plate, or the S1 vertebral plate hole can be opened first by the reamer wire, as shown in
The reamer can rotate, as shown by arrows, reaming a bone channel through the pathway defined by the reamer wire. The bone channel can extend from the Ilium to the S1 vertebral end plate. The reamer can have a reamer diameter from about 10 mm to about 23 mm, for example about 15.5 mm. The bone channel can have a bone channel diameter approximately equal to the reamer diameter.
During reaming, the reamer can experience more resistance from the cortical S1 vertebral end plate, indicating to the user that the reamer is approaching the intervertebral space (due to the change in bone density). The reaming can be performed with a visualization technique (e.g., fluoroscopy) to indicate the position of the reamer with respect to the surrounding anatomy. The reamer can ream the bone channel into the L5 vertebra or stop short of reaming the L5 vertebra (as shown). The bone reamed during the reaming process can be preserved for use later as a filler. The reamer can be threaded and/or have one or more cutting blades extending radially outward. Irrigation (e.g., or saline solution, anesthetic, antibiotics, or combinations thereof) and suction can be delivered to the treatment site before, during and/or after reaming, wire insertion, support device insertion, bone filler delivery, or combinations thereof.
The bone channel can have a bone channel longitudinal axis. The bone channel longitudinal axis can form an access angle with respect to the plane defined by the S1 vertebral end plate. The access angle can be from about 1° to about 90°, more narrowly from about 3° to about 40°, yet more narrowly from about 5° to about 30°, yet more narrowly from about 10° to about 25°, for example about 15°, about 20°, or about 25°.
a illustrates that the support device can have one, two, three or more support device segments in a linear arrangement rotatably attached to each other. The support device segments can have rectangular configurations. The support device segments can be rigid and/or flexible. For example, the support device segments can be configured to expand in height when compressed in length. After insertion into an intervertebral space, the support device segments can be longitudinally compressed and expand in height to fill the intervertebral space.
The support device segments can be attached to adjacent support device segments with one, two or three hinges, such as top hinges, middle hinges, bottom hinges, or a combination thereof. Although single hinge attachments between segments can be used, a multiple hinge attachment can be used when the hinges away from the rotation can detach, such as pop-fit hinges.
b illustrates that the adjacent segments can be rotatably attached by a single hinge. The hinge can be in a hinge track that can allow the hinge to translate vertically (as shown) or longitudinally with respect to the support device segment.
c illustrates that that support device segments can have a hinge link extending from a single end of the segment. The hinge link can have the hinge at the terminal end of the hinge link. The hinge link can have a smaller height than the remainder of the support device, for example allowing adjacent support device segments greater range of rotational motion with respect to the adjacent support device segment. For example, the support device segments can rotate up to about 300°, more narrowly up to about 270°, yet more narrowly up to about 240°, before interference fitting against the adjacent segment.
d illustrates that the support device segments can have a first hinge link extending from one end of the segment and a second hinge link extending from a second end of the segment. The hinge links from adjacent segments can attach to each other at a hinge. The support device segments can rotate up to about 330°, more narrowly up to about 270°, before interference fitting against the adjacent segment.
a illustrates that the support device can be inserted, as shown in translation by the arrow, through the bone channel.
The support device can enter the intervertebral space free of obstruction or can interference fit against (i.e., bump into) the L5 vertebral end plate, further passively articulating the support device segments and redirecting the support device further into the intervertebral bone space. The support device segments can be actively articulatable with respect to each other, for example by control through releasable cables or wires extending through a hollow channel in the support device and connected to the individual support device segments.
c illustrates that the support device can be completely positioned within the intervertebral space. The support device can be the entire width of the intervertebral space or less than the entire width of the intervertebral space (as shown). The support device can be longitudinally compressed, which for example can result in height expansion of the support device (such as for support devices with a structure having expandable struts or compressible expansion ramps between support device end plates).
A hollow channel or cavity in the support device and/or the intervertebral space outside of the support device can be filled with a filler, such as morselized bone (including autograft of the bone removed to create the hone channel), BMP, any material listed herein, or combinations thereof.
The support device can be fixed to the end plates with screws, staples, anchors, brads, hooks, epoxy or combinations thereof. For example, anchoring screws can be delivered through the bone channel.
d illustrates that the bone channel can be filled with a bone channel filler, such as morselized bone (including autograft of the bone removed to create the bone channel), BMP, any material listed herein, or combinations thereof.
a illustrates that the support device segments can each have proximal and distal chamfers, bevels, notches. The proximal and distal chamfers can be on the top side of the support device segments.
b illustrates that the top of the distal-most support device segment of the support device can have a distal chamfer. The top of the proximal-most support device segment of the support device can have a proximal chamfer. The remainder of the support device segments can have no significant chamfers.
c illustrates that the tops of the distal-most and proximal-most support device segments of the support device can have distal chamfers and proximal chamfers. The remainder of the support device segments can have no significant chamfers.
a illustrates that the support device can be inserted, as shown in translation by the arrow, through the bone channel.
c illustrates that similar to the support device shown and described in
d illustrates that similar to the support device shown and described in
a through 29d illustrate that the support device can be flexible. The support device can have one or more support device segments (shown as a single segment for illustrative purposes). The support device can be elastically or plastically deformable during insertion from the bone channel intro the intervertebral space. As shown in
c illustrates that similar to the support device shown and described in
d illustrates that similar to the support device shown and described in
Any or all elements of the device and/or other devices or apparatuses described herein can be made from, for example, a single or multiple stainless steel alloys, nickel titanium alloys (e.g., Nitinol), cobalt-chrome alloys (e.g., ELGILOY® from Elgin Specialty Metals, Elgin, Ill.; CONICHROME® from Carpenter Metals Corp., Wyomissing, Pa.), nickel-cobalt alloys (e.g., MP35N® from Magellan Industrial Trading Company, Inc., Westport, Conn.), molybdenum alloys (e.g., molybdenum TZM alloy, for example as disclosed in International Pub. No. WO 03/082363 A2, published 9 Oct. 2003, which is herein incorporated by reference in its entirety), tungsten-rhenium alloys, for example, as disclosed in International Pub. No. WO 03/082363, polymers such as polyethylene teraphathalate (PET)/polyester (e.g., DACRON® from E. I. Du Pont de Nemours and Company, Wilmington, Del.), polypropylene, (PET), polytetrafluoroethylene (PTFE), expanded PTFE (ePTFE), polyether ketone (PEK), polyether ether ketone (PEEK), poly ether ketone ketone (PEKK) (also poly aryl ether ketone ketone), nylon, polyether-block co-polyamide polymers (e.g., PEBAX® from ATOFINA, Paris, France), aliphatic polyether polyurethanes (e.g., TECOFLEX® from Thermedics Polymer Products, Wilmington, Mass.), polyvinyl chloride (PVC), polyurethane, thermoplastic, fluorinated ethylene propylene (FEP), absorbable or resorbable polymers such as polyglycolic acid (PGA), polylactic acid (PLA), polycaprolactone (PCL), polyethyl acrylate (PEA), polydioxanone (PDS), and pseudo-polyamino tyrosine-based acids, extruded collagen, silicone, zinc, echogenic, radioactive, radiopaque materials, a biomaterial (e.g., cadaver tissue, collagen, allograft, autograft, xenograft, bone cement, morselized bone, osteogenic powder, beads of bone) any of the other materials listed herein or combinations thereof. Examples of radiopaque materials are barium sulfate, zinc oxide, titanium, stainless steel, nickel-titanium alloys, tantalum and gold.
Any or all elements of the device and/or other devices or apparatuses described herein, can be, have, and/or be completely or partially coated with agents and/or a matrix a matrix for cell ingrowth or used with a fabric, for example a covering (not shown) that acts as a matrix for cell ingrowth. The matrix and/or fabric can be, for example, polyester (e.g., DACRON® from E. I. Du Pont de Nemours and Company, Wilmington, Del.), polypropylene, PTFE, ePTFE, nylon, extruded collagen, silicone or combinations thereof.
The device and/or elements of the device and/or other devices or apparatuses described herein and/or the fabric can be filled, coated, layered and/or otherwise made with and/or from cements, fillers, glues, and/or an agent delivery matrix known to one having ordinary skill in the art and/or a therapeutic and/or diagnostic agent. Any of these cements and/or fillers and/or glues can be osteogenic and osteoinductive growth factors.
Examples of such cements and/or fillers includes bone chips, demineralized bone matrix (DBM), calcium sulfate, coralline hydroxyapatite, biocoral, tricalcium phosphate, calcium phosphate, polymethyl methacrylate (PMMA), biodegradable ceramics, bioactive glasses, hyaluronic acid, lactoferrin, bone morphogenic proteins (BMPs) such as recombinant human bone morphogenetic proteins (rhBMPs), other materials described herein, or combinations thereof.
The agents within these matrices can include any agent disclosed herein or combinations thereof, including radioactive materials; radiopaque materials; cytogenic agents; cytotoxic agents; cytostatic agents; thrombogenic agents, for example polyurethane, cellulose acetate polymer mixed with bismuth trioxide, and ethylene vinyl alcohol; lubricious, hydrophilic materials; phosphor cholene; anti-inflammatory agents, for example non-steroidal anti-inflammatories (NSAIDs) such as cyclooxygenase-1 (COX-1) inhibitors (e.g., acetylsalicylic acid, for example ASPIRIN® from Bayer AG, Leverkusen, Germany; ibuprofen, for example ADVIL® from Wyeth, Collegeville, Pa.; indomethacin; mefenamic acid), COX-2 inhibitors (e.g., VIOXX® from Merck & Co., Inc., Whitehouse Station, N.J.; CELEBREX® from Pharmacia Corp., Peapack, N.J.; COX-1 inhibitors); immunosuppressive agents, for example Sirolimus (RAPAMUNE®, from Wyeth, Collegeville, Pa.), or matrix metalloproteinase (MMP) inhibitors (e.g., tetracycline and tetracycline derivatives) that act early within the pathways of an inflammatory response. Examples of other agents are provided in Walton et al, Inhibition of Prostoglandin E2 Synthesis in Abdominal Aortic Aneurysms, Circulation, Jul. 6, 1999, 48-54; Tambiah et al, Provocation of Experimental Aortic Inflammation Mediators and Chlamydia Pneumoniae, Brit. J. Surgery 88 (7), 935-940; Franklin et al, Uptake of Tetracycline by Aortic Aneurysm Wall and Its Effect on Inflammation and Proteolysis, Brit. J. Surgery 86 (6), 771-775; Xu et al, Spl Increases Expression of Cyclooxygenase-2 in Hypoxic Vascular Endothelium, J. Biological Chemistry 275 (32) 24583-24589; and Pyo et al, Targeted Gene Disruption of Matrix Metalloproteinase-9 (Gelatinase B) Suppresses Development of Experimental Abdominal Aortic Aneurysms, J. Clinical Investigation 105 (11), 1641-1649 which are all incorporated by reference in their entireties.
PCT Application Nos. PCT/US2011/000974, filed 27 May 2011; and PCT/US2011/048992, filed 24 Aug. 2011; and U.S. Provisional Application Nos. 61/349,151, filed 27 May 2010; 61/376,626, filed 24 Aug. 2010, are all incorporated by reference herein in their entireties.
Any elements described herein as singular can be pluralized (i.e., anything described as “one” can be more than one). Any species element of a genus element can have the characteristics or elements of any other species element of that genus. The above-described configurations, elements or complete assemblies and methods and their elements for carrying out the invention, and variations of aspects of the invention can be combined and modified with each other in any combination.
This application claims priority to U.S. Provisional Application No. 61/456,806 filed 12 Nov. 2010, which is incorporated by reference in its entirety.
Number | Name | Date | Kind |
---|---|---|---|
646119 | Clamer et al. | Mar 1900 | A |
4204531 | Aginsky | May 1980 | A |
4569338 | Edwards | Feb 1986 | A |
4636217 | Ogilvie et al. | Jan 1987 | A |
4653489 | Tronzo | Mar 1987 | A |
4716839 | Catena | Jan 1988 | A |
4716893 | Fischer et al. | Jan 1988 | A |
4725264 | Glassman | Feb 1988 | A |
4733665 | Palmaz | Mar 1988 | A |
4759769 | Hedman et al. | Jul 1988 | A |
4763644 | Webb | Aug 1988 | A |
4863476 | Shepperd | Sep 1989 | A |
4886062 | Wiktor | Dec 1989 | A |
4911718 | Lee et al. | Mar 1990 | A |
4932975 | Main et al. | Jun 1990 | A |
4941466 | Romano | Jul 1990 | A |
4969888 | Scholten et al. | Nov 1990 | A |
5007909 | Rogozinski | Apr 1991 | A |
5015247 | Michelson | May 1991 | A |
5026373 | Ray et al. | Jun 1991 | A |
5059193 | Kuslich | Oct 1991 | A |
5108404 | Scholten et al. | Apr 1992 | A |
5123926 | Pisharodi | Jun 1992 | A |
5139480 | Hickle et al. | Aug 1992 | A |
5171278 | Pisharodi | Dec 1992 | A |
5217483 | Tower | Jun 1993 | A |
5258031 | Salib et al. | Nov 1993 | A |
5306278 | Dahl et al. | Apr 1994 | A |
5324295 | Shapiro | Jun 1994 | A |
5342348 | Kaplan | Aug 1994 | A |
5345927 | Bonutti | Sep 1994 | A |
5390683 | Pisharodi | Feb 1995 | A |
5390898 | Smedley et al. | Feb 1995 | A |
5397364 | Kozak et al. | Mar 1995 | A |
5425773 | Boyd et al. | Jun 1995 | A |
5454365 | Bonutti | Oct 1995 | A |
5458643 | Oka et al. | Oct 1995 | A |
5480442 | Bertagnoli | Jan 1996 | A |
5484384 | Fearnot | Jan 1996 | A |
5496365 | Sgro | Mar 1996 | A |
5522899 | Michelson | Jun 1996 | A |
5534002 | Brumfield et al. | Jul 1996 | A |
5540690 | Miller et al. | Jul 1996 | A |
5549679 | Kuslich | Aug 1996 | A |
5554191 | Lahille et al. | Sep 1996 | A |
5556413 | Lam | Sep 1996 | A |
5562736 | Ray et al. | Oct 1996 | A |
5562738 | Boyd et al. | Oct 1996 | A |
5571189 | Kuslich | Nov 1996 | A |
5571192 | Schonhoffer | Nov 1996 | A |
5584831 | McKay | Dec 1996 | A |
5591197 | Orth et al. | Jan 1997 | A |
5593409 | Michelson | Jan 1997 | A |
5609356 | Mossi | Mar 1997 | A |
5609635 | Michelson | Mar 1997 | A |
5643264 | Sherman et al. | Jul 1997 | A |
5643312 | Fischell et al. | Jul 1997 | A |
5645560 | Crocker et al. | Jul 1997 | A |
5649950 | Bourne et al. | Jul 1997 | A |
5653763 | Errico et al. | Aug 1997 | A |
5658335 | Allen | Aug 1997 | A |
5665122 | Kambin | Sep 1997 | A |
5669909 | Zdeblick et al. | Sep 1997 | A |
5674295 | Ray et al. | Oct 1997 | A |
5683394 | Rinner | Nov 1997 | A |
5693100 | Pisharodi | Dec 1997 | A |
5702449 | McKay | Dec 1997 | A |
5702453 | Rabbe et al. | Dec 1997 | A |
5741253 | Michelson | Apr 1998 | A |
5749916 | Richelsoph | May 1998 | A |
5772661 | Michelson | Jun 1998 | A |
5776181 | Lee et al. | Jul 1998 | A |
5776197 | Rabbe et al. | Jul 1998 | A |
5776198 | Rabbe et al. | Jul 1998 | A |
5776199 | Michelson | Jul 1998 | A |
5782832 | Larsen et al. | Jul 1998 | A |
5782903 | Wiktor | Jul 1998 | A |
5785710 | Michelson | Jul 1998 | A |
5800520 | Fogarty et al. | Sep 1998 | A |
5824054 | Khosravi et al. | Oct 1998 | A |
5824093 | Ray et al. | Oct 1998 | A |
5827289 | Reiley et al. | Oct 1998 | A |
5827321 | Roubin et al. | Oct 1998 | A |
5853419 | Imran | Dec 1998 | A |
5861025 | Boudghene et al. | Jan 1999 | A |
5863284 | Klein | Jan 1999 | A |
5865848 | Baker | Feb 1999 | A |
5972015 | Scribner et al. | Oct 1999 | A |
5980522 | Koros et al. | Nov 1999 | A |
5980550 | Eder et al. | Nov 1999 | A |
5984957 | Laptewicz et al. | Nov 1999 | A |
6001130 | Bryan et al. | Dec 1999 | A |
6019765 | Thornhill et al. | Feb 2000 | A |
6019792 | Cauthen | Feb 2000 | A |
6022376 | Assell et al. | Feb 2000 | A |
6025104 | Fuller et al. | Feb 2000 | A |
6027527 | Asano et al. | Feb 2000 | A |
6036719 | Meilus | Mar 2000 | A |
6039761 | Li et al. | Mar 2000 | A |
6045579 | Hochshuler et al. | Apr 2000 | A |
6053916 | Moore | Apr 2000 | A |
6066154 | Reiley et al. | May 2000 | A |
6077246 | Kullas et al. | Jun 2000 | A |
6080193 | Hochshuler et al. | Jun 2000 | A |
6083522 | Chu et al. | Jul 2000 | A |
6086610 | Duerig et al. | Jul 2000 | A |
6090143 | Meriwether et al. | Jul 2000 | A |
6102950 | Vaccaro | Aug 2000 | A |
6113639 | Ray et al. | Sep 2000 | A |
6126689 | Brett | Oct 2000 | A |
6127597 | Beyar et al. | Oct 2000 | A |
6129763 | Chauvin et al. | Oct 2000 | A |
6132465 | Ray et al. | Oct 2000 | A |
6140452 | Felt et al. | Oct 2000 | A |
6146417 | Ischinger | Nov 2000 | A |
6159244 | Suddaby | Dec 2000 | A |
6159245 | Meriwether et al. | Dec 2000 | A |
6168616 | Brown, III | Jan 2001 | B1 |
6171312 | Beaty | Jan 2001 | B1 |
6176882 | Biedermann et al. | Jan 2001 | B1 |
6179874 | Cauthen | Jan 2001 | B1 |
6183506 | Penn et al. | Feb 2001 | B1 |
6183517 | Suddaby | Feb 2001 | B1 |
6193757 | Foley et al. | Feb 2001 | B1 |
6206910 | Berry et al. | Mar 2001 | B1 |
6206924 | Timm | Mar 2001 | B1 |
6224595 | Michelson | May 2001 | B1 |
6224603 | Marino | May 2001 | B1 |
6224604 | Suddaby | May 2001 | B1 |
6224607 | Michelson | May 2001 | B1 |
6235043 | Reiley et al. | May 2001 | B1 |
6241734 | Scribner et al. | Jun 2001 | B1 |
6245101 | Drasler et al. | Jun 2001 | B1 |
6245107 | Ferree | Jun 2001 | B1 |
6248110 | Reiley et al. | Jun 2001 | B1 |
6280456 | Scribner et al. | Aug 2001 | B1 |
6287332 | Bolz et al. | Sep 2001 | B1 |
6293967 | Shanley | Sep 2001 | B1 |
6302914 | Michelson | Oct 2001 | B1 |
6332895 | Suddaby | Dec 2001 | B1 |
6371989 | Chauvin et al. | Apr 2002 | B1 |
6395031 | Foley et al. | May 2002 | B1 |
6402750 | Atkinson et al. | Jun 2002 | B1 |
6402785 | Zdeblick et al. | Jun 2002 | B1 |
6409765 | Bianchi et al. | Jun 2002 | B1 |
6419704 | Ferree | Jul 2002 | B1 |
6419705 | Erickson | Jul 2002 | B1 |
6423083 | Reiley et al. | Jul 2002 | B2 |
6425916 | Garrison et al. | Jul 2002 | B1 |
6425919 | Lambrecht | Jul 2002 | B1 |
6428569 | Brown | Aug 2002 | B1 |
6432107 | Ferree | Aug 2002 | B1 |
6436098 | Michelson | Aug 2002 | B1 |
6436140 | Liu et al. | Aug 2002 | B1 |
6440168 | Cauthen | Aug 2002 | B1 |
6447544 | Michelson | Sep 2002 | B1 |
6447546 | Bramlet et al. | Sep 2002 | B1 |
6447547 | Michelson | Sep 2002 | B1 |
6451025 | Jervis | Sep 2002 | B1 |
6454804 | Ferree | Sep 2002 | B1 |
6468301 | Amplatz et al. | Oct 2002 | B1 |
6468302 | Coc et al. | Oct 2002 | B2 |
6478823 | Michelson | Nov 2002 | B1 |
6482235 | Lambrecht et al. | Nov 2002 | B1 |
6488710 | Besselink | Dec 2002 | B2 |
6491724 | Ferree | Dec 2002 | B1 |
6494883 | Ferree | Dec 2002 | B1 |
6508820 | Bales | Jan 2003 | B2 |
6508839 | Lambrecht et al. | Jan 2003 | B1 |
6514255 | Ferree | Feb 2003 | B1 |
6520991 | Huene | Feb 2003 | B2 |
6533817 | Norton et al. | Mar 2003 | B1 |
6554833 | Levy et al. | Apr 2003 | B2 |
6562074 | Gerbec et al. | May 2003 | B2 |
6582431 | Ray | Jun 2003 | B1 |
6582467 | Teitelbaum et al. | Jun 2003 | B1 |
6585770 | White et al. | Jul 2003 | B1 |
6592589 | Hajianpour | Jul 2003 | B2 |
6592625 | Cauthen | Jul 2003 | B2 |
6595998 | Johnson et al. | Jul 2003 | B2 |
6602291 | Ray et al. | Aug 2003 | B1 |
6607530 | Carl et al. | Aug 2003 | B1 |
6607544 | Boucher et al. | Aug 2003 | B1 |
6613054 | Scribner et al. | Sep 2003 | B2 |
6623505 | Scribner et al. | Sep 2003 | B2 |
6641587 | Scribner et al. | Nov 2003 | B2 |
6641614 | Wagner et al. | Nov 2003 | B1 |
6645213 | Sand et al. | Nov 2003 | B2 |
6645247 | Ferree | Nov 2003 | B2 |
6648917 | Gerbec et al. | Nov 2003 | B2 |
6648918 | Ferree | Nov 2003 | B2 |
6648920 | Ferree | Nov 2003 | B2 |
6652584 | Michelson | Nov 2003 | B2 |
6656178 | Veldhuizen et al. | Dec 2003 | B1 |
6663647 | Reiley et al. | Dec 2003 | B2 |
6666891 | Boehm, Jr. et al. | Dec 2003 | B2 |
6676665 | Foley et al. | Jan 2004 | B2 |
6679915 | Cauthen | Jan 2004 | B1 |
6685695 | Ferree | Feb 2004 | B2 |
6695760 | Winkler et al. | Feb 2004 | B1 |
6706068 | Ferree | Mar 2004 | B2 |
6706070 | Wagner et al. | Mar 2004 | B1 |
6709458 | Michelson | Mar 2004 | B2 |
6712853 | Kuslich | Mar 2004 | B2 |
6716216 | Boucher et al. | Apr 2004 | B1 |
6716247 | Michelson | Apr 2004 | B2 |
6719773 | Boucher et al. | Apr 2004 | B1 |
6723126 | Berry | Apr 2004 | B1 |
6726691 | Osorio et al. | Apr 2004 | B2 |
6733535 | Michelson | May 2004 | B2 |
6740090 | Cragg et al. | May 2004 | B1 |
6743255 | Ferree | Jun 2004 | B2 |
6746451 | Middleton et al. | Jun 2004 | B2 |
6758863 | Estes et al. | Jul 2004 | B2 |
6793656 | Mathews | Sep 2004 | B1 |
6793679 | Michelson | Sep 2004 | B2 |
6808537 | Michelson | Oct 2004 | B2 |
6814756 | Michelson | Nov 2004 | B1 |
6830589 | Erickson | Dec 2004 | B2 |
6852115 | Kinnett | Feb 2005 | B2 |
6852123 | Brown | Feb 2005 | B2 |
6852129 | Gerbec et al. | Feb 2005 | B2 |
6863673 | Gerbec et al. | Mar 2005 | B2 |
6893464 | Kiester | May 2005 | B2 |
6899716 | Baldwin | May 2005 | B2 |
6899719 | Reiley et al. | May 2005 | B2 |
6921264 | Mayer et al. | Jul 2005 | B2 |
6923813 | Phillips et al. | Aug 2005 | B2 |
6923830 | Michelson | Aug 2005 | B2 |
6936065 | Khan et al. | Aug 2005 | B2 |
6936070 | Muhanna | Aug 2005 | B1 |
6948223 | Shortt | Sep 2005 | B2 |
6953477 | Berry | Oct 2005 | B2 |
6955691 | Chae et al. | Oct 2005 | B2 |
6960215 | Olson et al. | Nov 2005 | B2 |
6962606 | Michelson | Nov 2005 | B2 |
6981981 | Reiley et al. | Jan 2006 | B2 |
7008453 | Michelson | Mar 2006 | B1 |
7018415 | McKay | Mar 2006 | B1 |
7018416 | Hanson et al. | Mar 2006 | B2 |
7056321 | Pagliuca et al. | Jun 2006 | B2 |
7060073 | Frey et al. | Jun 2006 | B2 |
7066961 | Michelson | Jun 2006 | B2 |
7077864 | Byrd, III et al. | Jul 2006 | B2 |
7087055 | Lim et al. | Aug 2006 | B2 |
7094257 | Mujwid et al. | Aug 2006 | B2 |
7097648 | Globerman et al. | Aug 2006 | B1 |
7112206 | Michelson | Sep 2006 | B2 |
7118598 | Michelson | Oct 2006 | B2 |
7135043 | Nakahara et al. | Nov 2006 | B2 |
7166110 | Yundt | Jan 2007 | B2 |
7201751 | Zucherman et al. | Apr 2007 | B2 |
7201775 | Gorensek et al. | Apr 2007 | B2 |
7204853 | Gordon et al. | Apr 2007 | B2 |
7211112 | Baynham et al. | May 2007 | B2 |
7212480 | Shoji et al. | May 2007 | B2 |
7223292 | Messerli et al. | May 2007 | B2 |
7226475 | Lenz et al. | Jun 2007 | B2 |
7226481 | Kuslich | Jun 2007 | B2 |
7226483 | Gerber et al. | Jun 2007 | B2 |
7238186 | Zdeblick et al. | Jul 2007 | B2 |
7241297 | Shaolian et al. | Jul 2007 | B2 |
7241303 | Reiss et al. | Jul 2007 | B2 |
7300440 | Zdeblick et al. | Nov 2007 | B2 |
7309338 | Cragg | Dec 2007 | B2 |
7311713 | Johnson et al. | Dec 2007 | B2 |
7316714 | Gordon et al. | Jan 2008 | B2 |
7318826 | Teitelbaum et al. | Jan 2008 | B2 |
7396360 | Lieberman | Jul 2008 | B2 |
7431735 | Liu et al. | Oct 2008 | B2 |
7452371 | Pavcnik et al. | Nov 2008 | B2 |
7503933 | Michelson | Mar 2009 | B2 |
7507241 | Levy et al. | Mar 2009 | B2 |
7582106 | Teitelbaum et al. | Sep 2009 | B2 |
7601172 | Segal et al. | Oct 2009 | B2 |
7618457 | Hudgins | Nov 2009 | B2 |
7621950 | Globerman et al. | Nov 2009 | B1 |
7722674 | Grotz | May 2010 | B1 |
7749228 | Lieberman | Jul 2010 | B2 |
7763028 | Lim et al. | Jul 2010 | B2 |
7828849 | Lim | Nov 2010 | B2 |
7837734 | Zucherman et al. | Nov 2010 | B2 |
7867233 | Shaolian et al. | Jan 2011 | B2 |
7875035 | Boucher et al. | Jan 2011 | B2 |
7879036 | Biedermann et al. | Feb 2011 | B2 |
7879082 | Brown | Feb 2011 | B2 |
8007498 | Mische | Aug 2011 | B2 |
8105382 | Olmos et al. | Jan 2012 | B2 |
8246622 | Siegal et al. | Aug 2012 | B2 |
20010007956 | Letac et al. | Jul 2001 | A1 |
20010034552 | Young et al. | Oct 2001 | A1 |
20020007218 | Cauthen | Jan 2002 | A1 |
20020010511 | Michelson | Jan 2002 | A1 |
20020022887 | Huene | Feb 2002 | A1 |
20020032444 | Mische | Mar 2002 | A1 |
20020052656 | Michelson | May 2002 | A1 |
20020068911 | Chan | Jun 2002 | A1 |
20020068939 | Levy et al. | Jun 2002 | A1 |
20020068975 | Teitelbaum et al. | Jun 2002 | A1 |
20020068976 | Jackson | Jun 2002 | A1 |
20020068977 | Jackson | Jun 2002 | A1 |
20020082598 | Teitelbaum | Jun 2002 | A1 |
20020082600 | Shaolian et al. | Jun 2002 | A1 |
20020091390 | Michelson | Jul 2002 | A1 |
20020095155 | Michelson | Jul 2002 | A1 |
20020099378 | Michelson | Jul 2002 | A1 |
20020111688 | Cauthen | Aug 2002 | A1 |
20020120337 | Cauthen | Aug 2002 | A1 |
20020123807 | Cauthen | Sep 2002 | A1 |
20020128713 | Ferree | Sep 2002 | A1 |
20020138077 | Ferree | Sep 2002 | A1 |
20020138133 | Lenz et al. | Sep 2002 | A1 |
20020138144 | Michelson | Sep 2002 | A1 |
20020143401 | Michelson | Oct 2002 | A1 |
20020151896 | Ferree | Oct 2002 | A1 |
20020151980 | Cauthen | Oct 2002 | A1 |
20020156530 | Lambrecht et al. | Oct 2002 | A1 |
20020161367 | Ferree | Oct 2002 | A1 |
20020161373 | Osorio et al. | Oct 2002 | A1 |
20020165542 | Ferree | Nov 2002 | A1 |
20020189622 | Cauthen et al. | Dec 2002 | A1 |
20020198526 | Shaolian et al. | Dec 2002 | A1 |
20030004511 | Ferree | Jan 2003 | A1 |
20030004574 | Ferree | Jan 2003 | A1 |
20030009227 | Lambrecht et al. | Jan 2003 | A1 |
20030014118 | Lambrecht et al. | Jan 2003 | A1 |
20030026788 | Ferree | Feb 2003 | A1 |
20030032963 | Reiss et al. | Feb 2003 | A1 |
20030040796 | Ferree | Feb 2003 | A1 |
20030040798 | Michelson | Feb 2003 | A1 |
20030050701 | Michelson | Mar 2003 | A1 |
20030065394 | Michelson | Apr 2003 | A1 |
20030065396 | Michelson | Apr 2003 | A1 |
20030074076 | Ferree et al. | Apr 2003 | A1 |
20030078579 | Ferree | Apr 2003 | A1 |
20030088249 | Furderer | May 2003 | A1 |
20030120345 | Cauthen | Jun 2003 | A1 |
20030125748 | Li et al. | Jul 2003 | A1 |
20030125807 | Lambrecht et al. | Jul 2003 | A1 |
20030135220 | Cauthen | Jul 2003 | A1 |
20030135279 | Michelson | Jul 2003 | A1 |
20030149482 | Michelson | Aug 2003 | A1 |
20030153976 | Cauthen et al. | Aug 2003 | A1 |
20030158553 | Michelson | Aug 2003 | A1 |
20030158604 | Cauthen et al. | Aug 2003 | A1 |
20030163200 | Cauthen | Aug 2003 | A1 |
20030181979 | Ferree | Sep 2003 | A1 |
20030181980 | Berry et al. | Sep 2003 | A1 |
20030181983 | Cauthen | Sep 2003 | A1 |
20030187507 | Cauthen | Oct 2003 | A1 |
20030187508 | Cauthen | Oct 2003 | A1 |
20030191536 | Ferree | Oct 2003 | A1 |
20030195514 | Trieu et al. | Oct 2003 | A1 |
20030195630 | Ferree | Oct 2003 | A1 |
20030195631 | Ferree | Oct 2003 | A1 |
20030199979 | McGuckin | Oct 2003 | A1 |
20030199981 | Ferree | Oct 2003 | A1 |
20030204260 | Ferree | Oct 2003 | A1 |
20030208270 | Michelson | Nov 2003 | A9 |
20030220643 | Ferree | Nov 2003 | A1 |
20030220650 | Major et al. | Nov 2003 | A1 |
20030220690 | Cauthen | Nov 2003 | A1 |
20030220693 | Cauthen | Nov 2003 | A1 |
20030220694 | Cauthen | Nov 2003 | A1 |
20030233097 | Ferree | Dec 2003 | A1 |
20030233148 | Ferree | Dec 2003 | A1 |
20030233188 | Jones | Dec 2003 | A1 |
20030236520 | Lim et al. | Dec 2003 | A1 |
20040002759 | Ferree | Jan 2004 | A1 |
20040002760 | Boyd et al. | Jan 2004 | A1 |
20040002769 | Ferree | Jan 2004 | A1 |
20040006341 | Shaolian et al. | Jan 2004 | A1 |
20040006344 | Nguyen et al. | Jan 2004 | A1 |
20040010315 | Song | Jan 2004 | A1 |
20040010318 | Ferree | Jan 2004 | A1 |
20040019386 | Ferree | Jan 2004 | A1 |
20040024400 | Michelson | Feb 2004 | A1 |
20040024459 | Ferree | Feb 2004 | A1 |
20040024460 | Ferree | Feb 2004 | A1 |
20040024461 | Ferree | Feb 2004 | A1 |
20040024462 | Ferree et al. | Feb 2004 | A1 |
20040024469 | Ferree | Feb 2004 | A1 |
20040024471 | Ferree | Feb 2004 | A1 |
20040028718 | Ferree | Feb 2004 | A1 |
20040030387 | Landry et al. | Feb 2004 | A1 |
20040030389 | Ferree | Feb 2004 | A1 |
20040030390 | Ferree | Feb 2004 | A1 |
20040030391 | Ferree | Feb 2004 | A1 |
20040030398 | Ferree | Feb 2004 | A1 |
20040034357 | Beane et al. | Feb 2004 | A1 |
20040044410 | Ferree et al. | Mar 2004 | A1 |
20040049289 | Tordy et al. | Mar 2004 | A1 |
20040059418 | McKay et al. | Mar 2004 | A1 |
20040059419 | Michelson | Mar 2004 | A1 |
20040059429 | Amin et al. | Mar 2004 | A1 |
20040068259 | Michelson | Apr 2004 | A1 |
20040082954 | Teitelbaum et al. | Apr 2004 | A1 |
20040082961 | Teitelbaum | Apr 2004 | A1 |
20040087950 | Teitelbaum | May 2004 | A1 |
20040092933 | Shaolian et al. | May 2004 | A1 |
20040092988 | Shaolian et al. | May 2004 | A1 |
20040097927 | Yeung et al. | May 2004 | A1 |
20040111108 | Farnan | Jun 2004 | A1 |
20040133229 | Lambrecht et al. | Jul 2004 | A1 |
20040133280 | Trieu | Jul 2004 | A1 |
20040138673 | Lambrecht et al. | Jul 2004 | A1 |
20040153064 | Foley et al. | Aug 2004 | A1 |
20040153065 | Lim | Aug 2004 | A1 |
20040153146 | Lashinski et al. | Aug 2004 | A1 |
20040167625 | Beyar et al. | Aug 2004 | A1 |
20050010292 | Carrasco | Jan 2005 | A1 |
20050015152 | Sweeney | Jan 2005 | A1 |
20050033431 | Gordon et al. | Feb 2005 | A1 |
20050038512 | Michelson | Feb 2005 | A1 |
20050043796 | Grant et al. | Feb 2005 | A1 |
20050070911 | Carrison et al. | Mar 2005 | A1 |
20050080422 | Otte et al. | Apr 2005 | A1 |
20050085910 | Sweeney | Apr 2005 | A1 |
20050107863 | Brown | May 2005 | A1 |
20050113919 | Cragg et al. | May 2005 | A1 |
20050113928 | Cragg et al. | May 2005 | A1 |
20050119561 | Kienzle | Jun 2005 | A1 |
20050143827 | Globerman et al. | Jun 2005 | A1 |
20050182463 | Hunter et al. | Aug 2005 | A1 |
20050187558 | Johnson et al. | Aug 2005 | A1 |
20050209698 | Gordon et al. | Sep 2005 | A1 |
20050228391 | Levy et al. | Oct 2005 | A1 |
20050240188 | Chow et al. | Oct 2005 | A1 |
20050249776 | Chen et al. | Nov 2005 | A1 |
20050261768 | Trieu | Nov 2005 | A1 |
20050278023 | Zwirkoski | Dec 2005 | A1 |
20050278026 | Gordon et al. | Dec 2005 | A1 |
20050278036 | Leonard et al. | Dec 2005 | A1 |
20060004455 | Leonard et al. | Jan 2006 | A1 |
20060015184 | Winterbottom et al. | Jan 2006 | A1 |
20060036241 | Siegal | Feb 2006 | A1 |
20060052788 | Thelen et al. | Mar 2006 | A1 |
20060052870 | Ferree | Mar 2006 | A1 |
20060058807 | Landry et al. | Mar 2006 | A1 |
20060058876 | McKinley | Mar 2006 | A1 |
20060058880 | Wysocki et al. | Mar 2006 | A1 |
20060085069 | Kim | Apr 2006 | A1 |
20060089715 | Truckai et al. | Apr 2006 | A1 |
20060100706 | Shadduck et al. | May 2006 | A1 |
20060106460 | Messerli et al. | May 2006 | A1 |
20060122701 | Kiester | Jun 2006 | A1 |
20060142859 | McLuen | Jun 2006 | A1 |
20060149239 | Winslow et al. | Jul 2006 | A1 |
20060149349 | Garbe | Jul 2006 | A1 |
20060149385 | McKay | Jul 2006 | A1 |
20060161261 | Brown et al. | Jul 2006 | A1 |
20060178694 | Greenhalgh et al. | Aug 2006 | A1 |
20060184188 | Li et al. | Aug 2006 | A1 |
20060200166 | Hanson et al. | Sep 2006 | A1 |
20060206207 | Dryer et al. | Sep 2006 | A1 |
20060235423 | Cantu | Oct 2006 | A1 |
20060241764 | Michelson | Oct 2006 | A1 |
20060253201 | McLuen | Nov 2006 | A1 |
20060264968 | Frey et al. | Nov 2006 | A1 |
20060271061 | Beyar et al. | Nov 2006 | A1 |
20060287725 | Miller | Dec 2006 | A1 |
20060287726 | Segal et al. | Dec 2006 | A1 |
20060287727 | Segal et al. | Dec 2006 | A1 |
20060287729 | Segal et al. | Dec 2006 | A1 |
20060287730 | Segal et al. | Dec 2006 | A1 |
20070027363 | Gannoe et al. | Feb 2007 | A1 |
20070032791 | Greenhalgh | Feb 2007 | A1 |
20070043440 | William et al. | Feb 2007 | A1 |
20070055375 | Ferree | Mar 2007 | A1 |
20070055377 | Hanson et al. | Mar 2007 | A1 |
20070067034 | Chirico et al. | Mar 2007 | A1 |
20070093897 | Gerbec et al. | Apr 2007 | A1 |
20070093899 | Dutoit et al. | Apr 2007 | A1 |
20070112428 | Lancial | May 2007 | A1 |
20070118222 | Lang | May 2007 | A1 |
20070162044 | Marino | Jul 2007 | A1 |
20070162135 | Segal et al. | Jul 2007 | A1 |
20070173824 | Rosen | Jul 2007 | A1 |
20070173830 | Rosen | Jul 2007 | A1 |
20070173939 | Kim et al. | Jul 2007 | A1 |
20070173940 | Hestad et al. | Jul 2007 | A1 |
20070208423 | Messerli et al. | Sep 2007 | A1 |
20070213717 | Trieu et al. | Sep 2007 | A1 |
20070225703 | Schmitz et al. | Sep 2007 | A1 |
20070233260 | Cragg | Oct 2007 | A1 |
20070239162 | Bhatnagar et al. | Oct 2007 | A1 |
20070244485 | Greenhalgh et al. | Oct 2007 | A1 |
20070255408 | Castleman et al. | Nov 2007 | A1 |
20070255409 | Dickson et al. | Nov 2007 | A1 |
20070260270 | Assell et al. | Nov 2007 | A1 |
20070260315 | Foley et al. | Nov 2007 | A1 |
20070270956 | Heinz | Nov 2007 | A1 |
20070270968 | Baynham et al. | Nov 2007 | A1 |
20070276377 | Yundt | Nov 2007 | A1 |
20070288028 | Gorensek et al. | Dec 2007 | A1 |
20080015694 | Tribus | Jan 2008 | A1 |
20080021558 | Thramann | Jan 2008 | A1 |
20080021559 | Thramann | Jan 2008 | A1 |
20080071356 | Greenhalgh et al. | Mar 2008 | A1 |
20080077150 | Nguyen | Mar 2008 | A1 |
20080140082 | Erdem et al. | Jun 2008 | A1 |
20080140207 | Olmos et al. | Jun 2008 | A1 |
20080147193 | Matthis et al. | Jun 2008 | A1 |
20080147194 | Grotz et al. | Jun 2008 | A1 |
20080183204 | Greenhalgh et al. | Jul 2008 | A1 |
20080188941 | Grotz | Aug 2008 | A1 |
20080221687 | Viker | Sep 2008 | A1 |
20080243254 | Butler | Oct 2008 | A1 |
20080249625 | Waugh et al. | Oct 2008 | A1 |
20080294205 | Greenhalgh et al. | Nov 2008 | A1 |
20080312743 | Vila et al. | Dec 2008 | A1 |
20080312744 | Vresilovic et al. | Dec 2008 | A1 |
20090018524 | Greenhalgh et al. | Jan 2009 | A1 |
20090024204 | Greenhalgh et al. | Jan 2009 | A1 |
20090024217 | Levy et al. | Jan 2009 | A1 |
20090054991 | Biyani et al. | Feb 2009 | A1 |
20090076511 | Osman | Mar 2009 | A1 |
20090149956 | Greenhalgh et al. | Jun 2009 | A1 |
20090163918 | Levy et al. | Jun 2009 | A1 |
20090182431 | Butler et al. | Jul 2009 | A1 |
20090198338 | Phan | Aug 2009 | A1 |
20090234398 | Chirico et al. | Sep 2009 | A1 |
20090240335 | Arcenio et al. | Sep 2009 | A1 |
20090318928 | Purcell et al. | Dec 2009 | A1 |
20100004750 | Segal et al. | Jan 2010 | A1 |
20100004751 | Segal et al. | Jan 2010 | A1 |
20100016905 | Greenhalgh et al. | Jan 2010 | A1 |
20100082109 | Greenhalgh et al. | Apr 2010 | A1 |
20100125274 | Greenhalgh et al. | May 2010 | A1 |
20100262147 | Siegal et al. | Oct 2010 | A1 |
20100292796 | Greenhalgh et al. | Nov 2010 | A1 |
20100324560 | Suda | Dec 2010 | A1 |
20110029083 | Hynes et al. | Feb 2011 | A1 |
20110054621 | Lim | Mar 2011 | A1 |
20110087296 | Reiley et al. | Apr 2011 | A1 |
20110106260 | Laurence et al. | May 2011 | A1 |
20110125266 | Rodgers et al. | May 2011 | A1 |
20110184519 | Trieu | Jul 2011 | A1 |
20110257684 | Sankaran | Oct 2011 | A1 |
20110282387 | Suh et al. | Nov 2011 | A1 |
20110319898 | O'Neil et al. | Dec 2011 | A1 |
20110320000 | O'Neil et al. | Dec 2011 | A1 |
Number | Date | Country |
---|---|---|
0734702 | Oct 1996 | EP |
0758541 | Feb 1997 | EP |
1804733 | Jul 2007 | EP |
2874814 | Nov 2007 | FR |
2900814 | Nov 2007 | FR |
2000-210315 | Aug 2000 | JP |
2002-535080 | Oct 2002 | JP |
2003-512887 | Apr 2003 | JP |
2004-511297 | Apr 2004 | JP |
2004-531355 | Oct 2004 | JP |
2004-321348 | Nov 2004 | JP |
662082 | May 1979 | SU |
WO 8803781 | Jun 1988 | WO |
WO 9214423 | Sep 1992 | WO |
WO 9531945 | Nov 1995 | WO |
WO 9603092 | Feb 1996 | WO |
WO 9700054 | Jan 1997 | WO |
WO 0030523 | Jun 2000 | WO |
WO 0044319 | Aug 2000 | WO |
WO 0044321 | Aug 2000 | WO |
WO 0132099 | May 2001 | WO |
WO 0178625 | Oct 2001 | WO |
WO 0195838 | Dec 2001 | WO |
WO 0213700 | Feb 2002 | WO |
WO 0232347 | Apr 2002 | WO |
WO 03003943 | Jan 2003 | WO |
WO 03003951 | Jan 2003 | WO |
WO 2005062900 | Jul 2005 | WO |
WO 2005096975 | Oct 2005 | WO |
WO 2005120400 | Dec 2005 | WO |
WO 2006023514 | Mar 2006 | WO |
WO 2006023671 | Mar 2006 | WO |
WO 2006026425 | Mar 2006 | WO |
WO 2006028971 | Mar 2006 | WO |
WO 2006034396 | Mar 2006 | WO |
WO 2006034436 | Mar 2006 | WO |
WO 2006037013 | Apr 2006 | WO |
WO 2006042334 | Apr 2006 | WO |
WO 2006050500 | May 2006 | WO |
WO 2006060420 | Jun 2006 | WO |
WO 2006072941 | Jul 2006 | WO |
WO 2006076712 | Jul 2006 | WO |
WO 2006086241 | Aug 2006 | WO |
WO 2006096167 | Sep 2006 | WO |
WO 2006116761 | Nov 2006 | WO |
WO 2006132945 | Dec 2006 | WO |
WO 2007009107 | Jan 2007 | WO |
WO 2007009123 | Jan 2007 | WO |
WO 2007016368 | Feb 2007 | WO |
WO 2007038611 | Apr 2007 | WO |
WO 2007041698 | Apr 2007 | WO |
WO 2007047098 | Apr 2007 | WO |
WO 2007050322 | May 2007 | WO |
WO 2007056433 | May 2007 | WO |
WO 2007062080 | May 2007 | WO |
WO 2007075411 | Jul 2007 | WO |
WO 2007079021 | Jul 2007 | WO |
WO 2007084257 | Jul 2007 | WO |
WO 2007084268 | Jul 2007 | WO |
WO 2007084810 | Jul 2007 | WO |
WO 2007100591 | Sep 2007 | WO |
WO 2007123920 | Nov 2007 | WO |
WO 2007124130 | Nov 2007 | WO |
WO 2007126622 | Nov 2007 | WO |
WO 2007130699 | Nov 2007 | WO |
WO 2007131026 | Nov 2007 | WO |
WO 2007133608 | Nov 2007 | WO |
WO 2007140382 | Dec 2007 | WO |
WO 2008005627 | Jan 2008 | WO |
WO 2008016598 | Feb 2008 | WO |
WO 2008070863 | Aug 2008 | WO |
WO 2009114381 | Sep 2009 | WO |
WO 2009130824 | Oct 2009 | WO |
WO 2012027490 | Mar 2012 | WO |
Entry |
---|
Franklin, I.J. et al., “Uptake of Tetracycline by Aortic Aneurysm Wall and Its Effect on Inflammation and Proteolysis,” Brit. J. Surger, 86(6):771-775, 1999. |
Pyo, R. et al., “Targeted Gene Disruption of Matrix Metalloproteinase-9 (Gelatinase B) Suppresses Development of Experimental Abdominal Aortic Aneurysms,” J. Clinical Investigation, 105(11):1641-1649, Jun. 2000. |
Tambiah, J. et al., “Provocation of Experimental Aortic Inflammation Mediators and Chlamydia pneumoniae,” Brit., J. Surgery, 88(7):935-940, Feb. 2001. |
Walton, L.J. et al., “Inhibition of Prostoglandin E2 Synthesis in Abdonminal Aortic Aneurysms,” Circulation, 48-54, Jul. 6, 1999. |
Xu. Q. at al., “Sp1 Increases Expression of Cyclooxygenase-2 in Hypoxic Vascular Endothelium,” J. Biological Chemistry, 275(32)24583-24589, Aug. 2000. |
Choi, G. et al., “Percutaneous Endoscopic Lumbar Discemtomy by Transiliac Approach,” Spine, 34(12):E443-446, May 20, 2009. |
Database WPI, Week 198004, Thomson Scientific, London, GB; AN 1980-A8866C, XP002690114, -& SU 662 082 A1 (Tartus Univ) May 15, 1979, abstract, figures 1,2. |
Number | Date | Country | |
---|---|---|---|
61456806 | Nov 2010 | US |